Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystem’s TaqMan OpenArray Genotyping System

Premium
Applied Biosystems announced this week the launch of the TaqMan OpenArray Genotyping System, a new analysis platform that allows researchers to perform faster and more cost-effective high-sample-throughput genotyping studies, the company said.
 
“This system expands the potential uses of TaqMan technology across a wide range of genotyping applications, providing an extremely fast, high-sample-throughput validation and screening tool for researchers in agricultural, pharmaceutical, and other commercial industries, as well as academic institutions,” ABI said in a statement.
 
Using this platform, which was developed as part of a collaboration between ABI and BioTrove, researchers can analyze “thousands to tens of thousands of samples in days, in contrast to weeks or months on alternative genotyping platforms.”
 
Researchers can use this platform to associate genotypes with complex diseases, ethnic ancestry, drug response, as well as traits for breeding and quality control in agricultural studies. 
 
ABI holds the exclusive rights to develop and market custom-built OpenArray plates of TaqMan SNP Genotyping Assays.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.